Skip to main content

Table 2 Levels of candidate biomarkers (ng/ml) as detected by specific ELISA assays

From: AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

 

Cirrhosis

Cirrhosis + HCC

 

Mean ± S.D.

median

Mean ± S.D.

median

AFP

5.96 ± 2.65

5.00

5934.66 ± 13025.02

92.50

PIVKAII

23.47 ± 59.69

7.83

135.17 ± 168.96

42.75

GP3

125.41 ± 281.05

29.62

161.41 ± 422.33

56.57

Follistatin

72.41 ± 76.16

50.20

87.33 ± 131.31

61.35

  1. The mean level between cirrhotic patients versus cirrhotic patients with cancer was significantly different in the cases of AFP and PIVKAII (p = 0.004 and p < 0.001 respectively, Wilcoxon). There was no significant difference between levels for GP3, CD5L or Follistatin.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us